Position in GH
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,050,210
+$403,620 QoQ
Shares Held
7,000
0.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#306
of 593 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026GUYASUTA INVESTMENT ADVISORS INC holds $60,978,057 across 5 Diagnostics & Research names. GH ranks #2 (1.7% of the industry book) .
All Filings in GH
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,050,210 | 7,000 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $646,590 | 7,000 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $714,980 | 7,000 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $421,115 | 6,740 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $350,749 | 6,740 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $287,124 | 6,740 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $205,907 | 6,740 | Shares | Sole | 2025-01-30 | |
| 2023-06-30 | $223,392 | 6,240 | Shares | Sole | 2023-07-17 | |
| 2022-09-30 | $335,899 | 6,240 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $251,721 | 6,240 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $413,337 | 6,240 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $624,124 | 6,240 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $780,062 | 6,240 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $774,945 | 6,240 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $952,536 | 6,240 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $804,211 | 6,240 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $697,507 | 6,240 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $506,251 | 6,240 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $434,304 | 6,240 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||